At the Heart of Matters: The Role of the Heart Team in Transcatheter Aortic Valve Replacement

The management of cardiovascular disease has seen revolutionary changes within the past decade. The treatment of valvular heart disease, and more specifically symptomatic aortic stenosis, has been at the epicenter of these changes. Transcatheter aortic valve replacement (TAVR) has filled the gap in the treatment of patients who were previously deemed inoperable; a number that could be as high as 40% of all patients with aortic stenosis [1]. Since the first TAVR on April 16, 2002, transcatheter valve technology has been improved and evaluation and selection of patients for this therapy refined, with rapid expansion.
Source: Trends in Cardiovascular Medicine - Category: Cardiology Authors: Source Type: research